uz
Feedback
๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

Kanalga Telegramโ€™da oโ€˜tish

ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ู„ู‡ู… ุตู„ ุนู„ู‰ ู…ุญู…ุฏ ูˆุขู„ ู…ุญู…ุฏ ู…ุญุชูˆู‰ ุงู„ู‚ู†ุงุฉ: ุดุฑูˆุญุงุช ุตูŠุฏู„ุฉ ุนุถูˆูŠุฉ ู…ุฑุญู„ุฉ ุซุงู†ูŠุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุซุงู„ุซุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุงูˆู„ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ุนู„ุงุฌูŠุงุช ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ู„ู„ุชูˆุงุตู„: @AronX2bot

Ko'proq ko'rsatish

๐Ÿ“ˆ Telegram kanali ๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ analitikasi

๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ (@aronstudy) Arab til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 13 355 obunachidan iborat bo'lib, Tibbiyot toifasida 1 923-o'rinni va Saudiya Arabistoni mintaqasida 5 681-o'rinni egallagan.

๐Ÿ“Š Auditoriya koโ€˜rsatkichlari va dinamika

ะฝะตะฒั–ะดะพะผะพ sanasidan buyon loyiha tez oโ€˜sib, 13 355 obunachiga ega boโ€˜ldi.

27 Iyun, 2026 dagi oxirgi maโ€™lumotlarga koโ€˜ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 213 ga, soโ€˜nggi 24 soatda esa -17 ga oโ€˜zgardi va umumiy qamrov yuqori darajada qolmoqda.

  • Tasdiqlash holati: Tasdiqlanmagan
  • Jalb etish (ER): Auditoriya oโ€˜rtacha 27.63% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 9.86% ini tashkil etuvchi reaksiyalarni toโ€˜playdi.
  • Post qamrovi: Har bir post oโ€˜rtacha 3 695 marta koโ€˜riladi; birinchi sutkada odatda 1 318 ta koโ€˜rish yigโ€˜iladi.
  • Reaksiyalar va oโ€˜zaro taโ€™sir: Auditoriya faol: har bir postga oโ€˜rtacha 36 ta reaksiya keladi.
  • Tematik yoโ€˜nalishlar: Kontent ู…ูŽุงุฏูŽู‘ุฉ, ุทูŽุงู„ูุจ, ุงูุณุชูุจููŠูŽุงู†, ุณูŽู„ูŽุงู…, ุฑูุณูŽุงู„ูŽุฉ kabi asosiy mavzularga jamlangan.

๐Ÿ“ Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida taโ€™riflaydi:
โ€œุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ู„ู‡ู… ุตู„ ุนู„ู‰ ู…ุญู…ุฏ ูˆุขู„ ู…ุญู…ุฏ ู…ุญุชูˆู‰ ุงู„ู‚ู†ุงุฉ: ุดุฑูˆุญุงุช ุตูŠุฏู„ุฉ ุนุถูˆูŠุฉ ู…ุฑุญู„ุฉ ุซุงู†ูŠุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุซุงู„ุซุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุงูˆู„ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ุนู„ุงุฌูŠุงุช ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ู„ู„ุชูˆุงุตู„: @AronX2botโ€

Yuqori yangilanish chastotasi (oxirgi maโ€™lumot 28 Iyun, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli boโ€˜lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim taโ€™sir nuqtasiga aylantirishini koโ€˜rsatadi.

13 355
Obunachilar
-1724 soatlar
+3037 kunlar
+21330 kunlar
Postlar arxiv
ุงุฎูŠุฑุงุงุงุงุง ๐Ÿ‡ฎ๐Ÿ‡ถ ู‡ุฑู…ู†ุง ู…ู† ุงุฌู„ ู‡ุฐู‡ ุงู„ู„ุญุธุฉ ุงู„ู ู…ุจุฑูˆูƒโค๏ธ

ุงู„ุซุงู†ูŠโค๏ธ ๐Ÿ‡ฎ๐Ÿ‡ถ ุจุณ ุบูŠุฑ ูŠุณุชู…ุฑูˆู† ู‡ูŠุฌ

ฺฉูˆูˆูˆูˆู„๐Ÿ‡ฎ๐Ÿ‡ถ ูŠุงุฑุจ ุชูƒู…ู„ ู„ู„ู†ู‡ุงูŠุฉ๐Ÿ™

ู…ู…ูƒู† ุชุญุชุงุฌูˆู†ู‡ุง

antidepressants cause this adverse effect? ๐Ÿ˜
antidepressants cause this adverse effect? ๐Ÿ˜

ุชููŠุฏูƒู… ๐Ÿ’ฏ

Although the treatment of GAD can be achieved by a wide range of medications. Acute and long-term therapy is best achieved by a. Venlafaxine b. Diazepam c. Hydroxyzine d. Buspirone e. All of them ูขู ูขูค ุฏูˆุฑ 1. ุดู†ูˆ ุงู„ุฌูˆุงุจุŸ ูˆู„ูˆ ูุฑุถุง ูƒุงู„ ุงุฑูŠุฏ ุนู„ุงุฌ ู„ู„ู€ acute anxiety ุดู†ูˆ ุงุฎุชุงุฑุŸ

ุฌุงู†ูˆ ูฃ ู…ู†ูˆ ู‡ู…ู‡ุŸ ูˆู…ู†ูˆ ู…ู† antidepressants ูŠุณุจุจ ุชุดูˆู‡ุงุช ููŠ ุงู„ุงุฌู†ุฉ